These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25095748)

  • 21. Telomerase activity and Bcl-2 expression in non-small cell lung cancer.
    Ohmura Y; Aoe M; Andou A; Shimizu N
    Clin Cancer Res; 2000 Aug; 6(8):2980-7. PubMed ID: 10955774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma.
    Petrişor O; Giuşcă SE; Sajin M; Dobrescu G; Căruntu ID
    Rom J Morphol Embryol; 2008; 49(2):163-71. PubMed ID: 18516322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.
    Stroescu C; Dragnea A; Ivanov B; Pechianu C; Herlea V; Sgarbura O; Popescu A; Popescu I
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):411-7. PubMed ID: 19104702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: distribution and prognostic relevance.
    Torsello A; Garufi C; Cosimelli M; Diodoro MG; Zeuli M; Vanni B; Campanella C; D'Angelo C; Sperduti I; Perrone Donnorso R; Cognetti F; Terzoli E; Mottolese M;
    Eur J Cancer; 2008 Jun; 44(9):1217-22. PubMed ID: 18424032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
    Fricke E; Keller G; Becker I; Rosivatz E; Schott C; Plaschke S; Rudelius M; Hermannstädter C; Busch R; Höfler H; Becker KF; Luber B
    Int J Cancer; 2003 Mar; 104(1):60-5. PubMed ID: 12532420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma.
    Allal AS; Waelchli L; Bründler MA
    Clin Cancer Res; 2003 Dec; 9(17):6489-96. PubMed ID: 14695153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray.
    Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Miwa S; Tsuneyama K; Takano Y
    J Clin Pathol; 2007 Mar; 60(3):273-7. PubMed ID: 16714395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
    Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of p53 and Ki67 proteins expression in Greek gastric cancer patients.
    Tzanakis NE; Peros G; Karakitsos P; Giannopoulos GA; Efstathiou SP; Rallis G; Tsigris C; Kostakis A; Nikiteas NI
    Acta Chir Belg; 2009 Oct; 109(5):606-11. PubMed ID: 19994803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ki-67 expression in gastric cancer. Results from a prospective study with long-term follow-up.
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2010; 51(4):655-61. PubMed ID: 21103622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors.
    Menezes HL; Jucá MJ; Gomes EG; Nunes BL; Costa HO; Matos D
    Arq Gastroenterol; 2010; 47(2):141-7. PubMed ID: 20721457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of Ki-67, p53, and Bcl-2 expression in prostate cancer patients with lymph node metastases: a retrospective immunohistochemical analysis.
    Masuda M; Takano Y; Iki M; Asakura T; Hashiba T; Noguchi S; Hosaka M
    Pathol Int; 1998 Jan; 48(1):41-6. PubMed ID: 9589463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of p53, p21WAF1/C1PI, and bcl-2 in radioresistant colorectal carcinoma.
    Palazzo JP; Kafka NJ; Grasso L; Chakrani F; Hanau C; Cuesta KH; Mercer WE
    Hum Pathol; 1997 Oct; 28(10):1189-95. PubMed ID: 9343326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p150 overexpression in gastric carcinoma: the association with p53, apoptosis and cell proliferation.
    Chen G; Burger MM
    Int J Cancer; 2004 Nov; 112(3):393-8. PubMed ID: 15382063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of p53 predicts shorter survival in diffuse type gastric cancer.
    Lee WJ; Shun CT; Hong RL; Wu MS; Chang KJ; Chen KM
    Br J Surg; 1998 Aug; 85(8):1138-42. PubMed ID: 9718015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
    Hofmockel G; Wittmann A; Dammrich J; Bassukas ID
    Anticancer Res; 1996; 16(6B):3807-11. PubMed ID: 9042262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.
    Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T
    Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Factors of Prostate Cancer in Tunisian Men: Immunohistochemical Study.
    Missaoui N; Abdelkarim SB; Mokni M; Hmissa S
    Asian Pac J Cancer Prev; 2016; 17(5):2655. PubMed ID: 27268646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.